Sabra Healthcare REIT (NASDAQ:SBRA) Issues FY 2026 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.540-1.550 for the period, compared to the consensus EPS estimate of 1.520.

Analysts Set New Price Targets

A number of equities research analysts have commented on SBRA shares. Wells Fargo & Company decreased their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a report on Monday, October 19th. Truist Financial upped their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Barclays cut their target price on Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 13th. Mizuho set a $21.00 target price on Sabra Healthcare REIT in a research report on Monday, August 31st. Finally, Huntington initiated coverage on Sabra Healthcare REIT in a research note on Monday. They set a “strong-buy” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $21.50.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $21.09 on Thursday. Sabra Healthcare REIT has a one year low of $17.53 and a one year high of $22.77. The company’s fifty day moving average price is $19.86 and its 200-day moving average price is $19.98. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.07 and a current ratio of 1.21. The company has a market capitalization of $5.39 billion, a PE ratio of 75.32, a price-to-earnings-growth ratio of 1.85 and a beta of 0.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). The company had revenue of $249.57 million for the quarter, compared to the consensus estimate of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. Sabra Healthcare REIT’s revenue was up 31.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.38 EPS. On average, equities analysts anticipate that Sabra Healthcare REIT will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be paid a $0.30 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.20 annualized dividend and a yield of 5.7%. Sabra Healthcare REIT’s payout ratio is presently 428.57%.

Insider Activity at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the transaction, the chief executive officer owned 1,657,686 shares of the company’s stock, valued at $34,529,599.38. This represents a 10.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by company insiders.

Sabra Healthcare REIT News Roundup

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 earnings guidance to $1.54–$1.55 per share, above the cited $1.52 consensus, and increased the midpoint of its normalized FFO outlook by $0.005 per share. Management expects 7%–8% year-over-year earnings growth in 2026. Sabra Health Care REIT Q3 Adjusted FFO, Revenue Rise; 2026 Guidance Lifted
• Positive Sentiment: Senior housing operations showed strength: third-quarter same-store senior housing occupancy reached 89.2%. Sabra is targeting 50% exposure to its senior housing operating portfolio (SHOP) by year-end 2027, positioning it for further growth, though this strategy increases exposure to operating performance. Sabra Health Care: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Huntington initiated coverage with a “strong-buy” rating, adding a bullish analyst view. Huntington stock recommendations
• Neutral Sentiment: The company declared a quarterly dividend of $0.30 per share, equivalent to $1.20 annually; shareholders of record November 13 are scheduled to be paid November 30. Sabra Health Q3 2026 earnings call transcript
• Neutral Sentiment: Sabra’s leadership team plans to attend Nareit’s REITworld conference November 16–19; the announcement did not include new financial guidance. Sabra to Attend Nareit’s REITworld 2026 Annual Conference
• Negative Sentiment: A valuation-focused article argues SBRA may be overvalued after a 107% five-year gain, which could temper enthusiasm despite improved operating trends. Sabra Health Care REIT Stock Looks Overvalued As Its 107% Five Year Run Continues

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.